Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Understanding how antidepressant drugs exert their effects in the human brain remains a major challenge in neuropsychopharmacology. In this talk, I will present our recent efforts to translate key findings from preclinical animal models into human neurocognitive paradigms of antidepressant drug action including behavioural and imaging approaches. I will discuss work spanning both established antidepressant medications and fast-acting, next-generation treatments, including ketamine. By integrating animal and human approaches, this work aims to bridge mechanistic insights across species and improve the way in which treatments for depression are understood and developed.
